ARCHIVES

NCI plans 18 percent budget cuts for large R01s, smaller cuts to other research project grants. NCI treatment division director Ellen Feigal accepts position with Translational Genomics Research Institute in Phoeniz, Ariz.

This article is from The Cancer Letter archive.

Vol. 30 No. 11 | March 12, 2004

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

September 28, 2001

Report From The Front Lines In War On Cancer Past, Present.

March 3, 2000

FDA Considering Ways To Improve Process Of Secondary Approvals Of Cancer Drugs

November 1, 1991

Garb’s Fight Now A Personal One

March 20, 1981

Study Finds Comparable Accuracy For Virtual And Standard Colonoscopy

September 26, 2008

Kennedy Bill Would Extend Cancer Program Three Years, Kill Budget Bypass

May 4, 1979